Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial
British Journal of Surgery · 03.04.2024 · 111 (4)
DOI: 10.1093/bjs/znae099 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Surgery, online erschienen am 23.04.2024. Verfasst von Juxian Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hepatobiliary Surgery, First Affiliated Hospital, Army Military Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Laparoscopy, Hepatectomy. Die Arbeit wurde bisher 23-mal zitiert (Crossref). Gefördert von: Special Project Fund for Clinical Research of the First Affiliated Hospital of Army Military Medical University.
Abstract (Originalsprache)
Background
The aim of this study was to compare the efficacy of laparoscopic liver resection versus radiofrequency ablation for treatment of small hepatocellular carcinoma.
Methods
This single-centre RCT was conducted at a tertiary referral centre in China. Patients with small hepatocellular carcinoma who had a single nodule no larger than 5 cm, or up to three nodules of 3 cm or smaller, were eligible. Patients were assigned randomly in a 1 : 1 ratio to either laparoscopic liver resection or radiofrequency ablation. Blinding was not attempted. Sample size calculations led to 75 patients per group. The primary outcome was overall survival, and the secondary outcome was recurrence-free survival.
Results
Seventy-five patients were included in each group. Overall survival (HR 1.26, 95% c.i. 0.69 to 2.30; P = 0.451) and recurrence-free survival (HR 1.34, 0.86 to 2.08; P = 0.189) did not differ between the resection and ablation groups. The 1-, 3- and 5-year overall survival rates were 94.7, 80.0, and 74.7% respectively after laparoscopic liver resection versus 93.3, 78.7, and 67.9% after radiofrequency ablation. Corresponding recurrence-free survival rates were 78.7, 61.3, and 51.6%, and 69.3, 53.3, and 41.0%, respectively.
Conclusion
For small hepatocellular carcinoma, percutaneous radiofrequency ablation provides therapeutic effects similar to those of laparoscopic liver resection. Registration number NCT02243384 (http://www.clinicaltrials.gov).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Hepatobiliary Surgery, First Affiliated Hospital, Army Military Medical University, Chongqing, China.
- Department of Hepatobiliary Surgery, 925th Hospital of the Chinese People's Liberation Army, Guiyang, China.
ORCID-Profile: Kuansheng Ma
Förderung
- Special Project Fund for Clinical Research of the First Affiliated Hospital of Army Military Medical University
Zitieren
APA
Song, J., Cao, L., Ma, K., Li, J., Wang, X., Chen, J., & Zheng, S. (2024). Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial. British Journal of Surgery, 111(4). https://doi.org/10.1093/bjs/znae099
Vancouver
Song J, Cao L, Ma K, Li J, Wang X, Chen J, et al. Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial. British Journal of Surgery. 2024;111(4). doi:10.1093/bjs/znae099
BibTeX
@article{Song2024,
author = {Song, Juxian and Cao, Li and Ma, Kuansheng and Li, Jianwei and Wang, Xiaojun and Chen, Jian and Zheng, Shuguo},
title = {Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial},
journal = {British Journal of Surgery},
year = {2024},
volume = {111},
number = {4},
doi = {10.1093/bjs/znae099}
}
EUVIMED